Pharmacological therapies for raising HDL cholesterol beyond synthetic small molecules

Current Opinion in Investigational Drugs

Volumn 9, Issue 3, 2008, Pages 274-280

  Garcia R A ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Atherosclerosis; Biological; Cholesterol; Coronary artery disease; HDL; Plaque; Small molecule

Indexed keywords

2 METHYLPROPANETHIOIC ACID S [2 [1 (2 ETHYLBUTYL)CYCLOHEXYLCARBOXAMIDO]PHENYL] ESTER; 5 A; 518 P; ANTIBODY; CET 1; CETI 7; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; CRD 5; CSL 111; D4 F; DNA VACCINE; ETC 216; ETC 588; ETC 642; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOSOME; MK 0859; PEPTIDE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; TORCETRAPIB; UNCLASSIFIED DRUG; VACCINE;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DRUG MEGADOSE; DRUG TARGETING; HUMAN; LOW DRUG DOSE; NONHUMAN; REVIEW;

ANIMALS; ANTIBODIES; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; HUMANS; LIPOSOMES; MOLECULAR MIMICRY; PHOSPHOLIPIDS; VACCINES;

EID: 40049090352     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)